Efficacy of doxycycline, azithromycin, or trovafloxacin for treatment of experimental Rocky Mountain spotted fever in dogs

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 4, 1999, Pages 813-821

  Breitschwerdt, E B ^a   Papich, M G ^a   Hegarty, B C ^a   Gilger, B ^a   Hancock, S I ^a   Davidson, M G ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; DOXYCYCLINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE DERIVATIVE; TROVAFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; DOG; DRUG EFFICACY; EXPERIMENTAL INFECTION; GENE AMPLIFICATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETINA BLOOD VESSEL; RICKETTSIA RICKETTSII; ROCKY MOUNTAIN SPOTTED FEVER; THROMBOCYTE COUNT; TISSUE CULTURE;

EID: 0032918405     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.4.813     Document Type: Article

References (26)

1. Archibald, L. K., and D. J. Sexton. 1995. Long-term sequelae of Rocky Mountain spotted fever. Clin. Infect. Dis. 20:1122-1125.
2. Bergeron, J. W., R. L. Braddom, and D. L. Kaelin. 1997. Persisting impairment following Rocky Mountain spotted fever: a case report. Arch. Phys. Med. Rehabil. 78:1277-1280.
3. Breitschwerdt, E. B., D. J. Meuten, D. H. Walker, M. G. Levy, K. Kennedy, M. King, and B. C. Curtis. 1985. Canine Rocky Mountain spotted fever: a kennel epizootic. Am. J. Vet. Res. 46:2124-2128.
4. Breitschwerdt, E. B., M. G. Levy, M. G. Davidson, D. H. Walker, W. Burgdorfer, B. C. Curtis, and C. A. Babineau. 1990. Kinetics of IgM and IgG responses to experimental and naturally acquired Rickettsia rickettsii infection in dogs. Am. J. Vet. Res. 51:1312-1316.
5. Breitschwerdt, E. B., M. G. Davidson, D. P. Aucoin, M. G. Levy, N. S. Szabados, B. C. Hegarty, A. L. Kuehne, and R. L. James. 1991. Efficacy of chloramphenicol, enrofloxacin, and tetracycline for treatment of experimental Rocky Mountain spotted fever in dogs. Antimicrob. Agents Chemother. 35:2375-2381.
6. Breitschwerdt, E. B., M. G. Davidson, B. C. Hegarty, M. G. Papich, and C. B. Grindem. 1997. Prednisolone at anti-inflammatory or immunosuppressive dosages in conjunction with doxycycline does not potentiate the severity of Rickettsia rickettsii infection in dogs. Antimicrob. Agents Chemother. 41: 141-147.
7. Dalton, M. J., M. J. Clarke, R. C. Holman, J. W. Krebs, D. B. Fishbein, J. G. Olsen, and J. E. Childs. 1995. National surveillance for Rocky Mountain spotted fever, 1981-1992: epidemiologic summary and evaluation of risk factors for fatal outcome. Am. J. Trop. Med. Hyg. 52:405-413.
8. Davidson, M. G., E. B. Breitschwerdt, D. H. Walker, M. G. Levy, C. S. Carlson, E. M. Hardie, C. A. Grindem, and M. P. Nasisse. 1990. Vascular permeability and coagulation during Rickettsia rickettsii infection in dogs. Am. J. Vet. Res. 51:165-170.
9. Drancourt, M., F. George, P. Brouqui, J. Sampol, and D. Raoult. 1992. Diagnosis of Mediterranean spotted fever by indirect immunofluorescence of Rickettsia conorii in circulating endothelial cells isolated by monoclonal coated immunomagnetic beads. J. Infect. Dis. 166:660-663.
10. Dunn, C. J., and L. B. Barradell. 1996. Azithromycin. A review of its pharmacological properties and use as 3-day therapy in respiratory tract infections. Drugs 51:483-505.
11. Felmingham, D., M. J. Robbins, K. Ingley, I. Mathias, H. Bhogal, A. Leakey, G. L. Ridgway, and R. N. Gruneberg. 1997. In-vitro activity of trovafloxacin, a new fluoroquinolone, against recent clinical isolates. J. Antimicrob. Chemother. 39(Suppl. B):43-49.
12. Greene, C. E., W. Burgdorfer, R. Cavagnolo, R. N. Philip, and M. G. Peacock. 1985. Rocky Mountain spotted fever in dogs and its differentiation from canine ehrlichiosis. J. Am. Vet. Med. Assoc. 186:465-472.
13. Johnson, T. A., and D. W. Wichern. 1988. Applied multivariate statistical analysis, 2nd ed., p. 607. Prentice-Hall, Inc., Englewood Cliffs, N.J.
14. Kapusnik-Uner, J. E., M. A. Sande, and H. F. Chambers. 1996. Tetracyclines, chloramphenicol, erythromycin, and miscellaneous antibacterial agents. In J. G. Hardman, L. E. Limbird, P. B. Molinoff, R. W. Ruddon, and A. G. Gilman (ed.), Goodman and Gilman's The pharmacological basis of therapeutics, 9th ed. McGraw-Hill, New York, N.Y.
15. Kenyon, R. H., W. M. Acree, G. G. Wright, and F. W. Melchior, Jr. 1972. Preparation of vaccines for Rocky Mountain spotted fever from rickettsiae propagated in cell culture. J. Infect. Dis. 125:146-152.
16. Kirkland, K. B., P. K. Marcom, D. J. Sexton, J. S. Dumler, and D. H. Walker. 1993. Rocky Mountain spotted fever complicated by gangrene: report of six cases and review. Clin. Infect. Dis. 16:629-634.
17. Kirkland, K. B., W. E. Wilkinson, and D. J. Sexton. 1995. Therapeutic delay and mortality in cases of Rocky Mountain spotted fever. Clin. Infect. Dis. 20:1118-1121.
18. Lissman, B. A., and J. L. Benach. 1980. Rocky Mountain spotted fever in dogs. J. Am. Vet. Med. Assoc. 176:994-995.
19. Lode, H., K. Borner, P. Koeppe, and T. Schaberg. 1996. Azithromycin -review of key chemical pharmacokinetic and microbiologic features. J. Antimicrob. Chemother. 37(Suppl. C):1-8.
20. McKoy, G. K. (ed.). 1998. Drug information, p. 242, 404-406. American Society of Health-System Pharmacists, Inc. Bethesda, Md.
21. Rutgers, C., J. Kowalski, C. R. Cole, R. G. Scherding, D. J. Chew, D. Davenport, M. O'Grady, and R. J. Murtaugh. 1985. Severe Rocky Mountain spotted fever in five dogs. J. Am. Anim. Hosp. Assoc. 21:361-369.
22. Sexton, D. J., S. S. Kanj, K. H. Wilson, G. R. Corey, B. C. Hegarty, M. G. Levy, and E. B. Breitschwerdt. 1994. The use of a polymerase chain reaction as a diagnostic test for Rocky Mountain spotted fever. Am. J. Trop. Med. Hyg. 50:59-63.
23. Shepard, R. M., and F. C. Faulkner. 1990. Pharmacokinetics of azithromycin in rats and dogs. J. Antimicrob. Chemother. 25(Suppl. A):49-60.
24. Treadway, G., and D. Pontani. 1996. Paediatric safety of azithromycin: worldwide experience. J. Antimicrob. Chemother. 37(Suppl. C):143-149.
25. Tzianabos, T., B. E. Anderson, and J. E. McDade. 1989. Detection of Rickettsia rickettsii DNA in clinical specimens using polymerase chain reaction technology. J. Clin. Microbiol. 27:2866-2868.
26. Wilson, K. H., R. Blitchington, P. Shah, G. McDonald, R. D. Gilmore, and L. P. Mallavia. 1989. Probe directed at a segment of Rickettsia rickettsii rRNA amplified with polymerase chain reaction. J. Clin. Microbiol. 27:2692-2696.